Digital ulcers associated with scleroderma: A major unmet medical need
- PMID: 39323322
- DOI: 10.1111/wrr.13224
Digital ulcers associated with scleroderma: A major unmet medical need
Abstract
Scleroderma or systemic sclerosis (SSc)-associated digital ischaemic complications, such as digital ulcers (SSc-DUs), appear relatively early during the disease course and are a major burden with substantial deterioration of quality of life. Expert rheumatologist and wound specialists have defined a DU; however, international application of the definition is still disorganised. Appearance of SSc-DUs is secondary to the onset of Raynaud's phenomenon and as a consequence, recommended first-line of treatment mainly includes vasodilators; however, many DUs are refractory to this treatment. Despite important practical issues, such as a lack of well-characterised SSc-wound healing animal model, significant efforts are needed to mechanistically understand the pathogenesis of SSc-DUs for developing clinically targetable disease modifying therapies.
Keywords: chronic wound; connective tissue; rheumatology; scleroderma.
© 2024 The Wound Healing Society.
References
REFERENCES
-
- Li JX. Secular trends in systemic sclerosis mortality in the United States from 1981 to 2020. Int J Environ Res Public Health. 2022;19:15088.
-
- Bukiri H, Volkmann ER. Current advances in the treatment of systemic sclerosis. Curr Opin Pharmacol. 2022;64:102211.
-
- Leask A, Naik A, Stratton RJ. Back to the future: targeting the extracellular matrix to treat systemic sclerosis. Nat Rev Rheumatol. 2023;19:713‐723.
-
- Boin F, Hummers LK. Scleroderma‐like fibrosing disorders. Rheum Dis Clin North Am. 2008;34:199‐220.
-
- Showalter K, Gordon JK. Skin histology in systemic sclerosis: a relevant clinical biomarker. Curr Rheumatol Rep. 2021;23:3.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical